Incyte Corp

NAS:INCYHealthcareNASDAQ:NBINASDAQ:NQUSMG

$116.00+2.43%LiveIn session · ≈ AED 426.01 · Market cap $23.17B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	95.1%	94.9%	93.9%	93.1%	92.6%	92.8%	—	—
Operating margin	−9.9%	19.6%	17.4%	17.7%	2.4%	26.1%	26.1%	+0.0 pts
Net margin	−11.1%	31.8%	10.0%	16.2%	0.8%	25.0%	25.0%	+0.0 pts
EBITDA margin	−6.7%	21.1%	17.7%	24.9%	9.6%	34.2%	—	—
Return on equity	−11.3%	25.2%	7.8%	11.5%	0.9%	24.9%	24.9%	+0.0 pts
Return on assets	−8.3%	19.2%	5.8%	8.8%	0.6%	18.5%	18.5%	+0.0 pts
Return on capital employed	−9.0%	14.4%	12.6%	11.8%	2.7%	24.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	1.3%	0.9%	0.7%	0.6%	0.8%	1.0%	—	—
Interest coverage	−121.3×	307.0×	221.9×	256.9×	44.4×	553.0×	—	—
Current ratio	3.7×	3.7×	3.5×	3.7×	2.0×	3.3×	3.3×	+0.0%
Quick ratio	3.7×	3.6×	3.5×	3.7×	1.9×	3.2×	—	—
Cash ratio	2.4×	2.4×	2.6×	2.6×	1.0×	2.0×	2.0×	+0.0%
Asset turnover	0.7×	0.6×	0.6×	0.5×	0.8×	0.7×	—	—
Inventory turnover	8.0×	5.4×	4.9×	4.0×	5.3×	3.7×	—	—
Receivables turnover	5.5×	4.8×	5.3×	5.0×	5.0×	5.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.